Roche Holding AG
SIX:ROG
Roche Holding AG
Deferred Income Tax
Roche Holding AG
Deferred Income Tax Peer Comparison
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Deferred Income Tax
CHf593m
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-7%
|
|
Novartis AG
SIX:NOVN
|
Deferred Income Tax
$2.3B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Deferred Income Tax
$286m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Deferred Income Tax?
Deferred Income Tax
593m
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Deferred Income Tax amounts to 593m CHF.
What is Roche Holding AG's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-7%
Over the last year, the Deferred Income Tax growth was -8%. The average annual Deferred Income Tax growth rates for Roche Holding AG have been 19% over the past three years , 9% over the past five years , and -7% over the past ten years .